News about Global Pharma

Optinose Receives FDA Approval for XHANCE Nasal Spray to Treat Chronic Sinusitis Without Nasal Polyps

Chronic sinusitis, affecting around 30 million adults in the United States, is a prevalent chronic condition that significantly impacts patients' quality of life.

Global Pharma | 16/03/2024 | By Manvi |  1802

Bioretec Receives FDA Breakthrough Device Designation for RemeOs Spinal Interbody Cage Implant

The RemeOs Spinal Interbody Cages, designed to restore intervertebral height and facilitate intervertebral body fusion in the cervical spine, are poised to revolutionize treatment options for patients with spinal conditions.

Global Pharma | 16/03/2024 | By Manvi |  699

Vapotherm to Unveil Access365 Home Ventilation Solution at MEDTRADE

Vapotherm, Inc. announced the debut of its Access365™ Home Ventilation Solution at the upcoming MEDTRADE conference.

Global Pharma | 15/03/2024 | By Manvi |  291

Cardinal Health Announces Approved Science-Based Climate Targets; Expands Focus Across Supply Chain

Cardinal Health announced that the company has received approval by the Science Based Targets initiative (SBTi) for its near-term science-based greenhouse gas (GHG) emissions reduction targets.

Global Pharma | 15/03/2024 | By Manvi |  618

FDA Approves Rezdiffra (resmetirom) for Treatment of NASH with Liver Scarring

NASH, a consequence of nonalcoholic fatty liver disease, can lead to liver inflammation and scarring over time, resulting in liver dysfunction.

Global Pharma | 15/03/2024 | By Abha |  1988

CPHI Japan 2024 to See More Than 20 percent Year-on-Year Rise

The event is widely seen as a barometer of overall health in the country’s pharma industry and in light of significant R&D growth, Tides will collaborate with CPHI Japan to introduce a free conference.

Global Pharma | 14/03/2024 | By Manvi |  983

Amolyt Pharma Enters into Definitive Agreement to be Acquired by AstraZeneca

AstraZeneca to acquire Amolyt Pharma at a purchase price of USD 800 million upfront and a potential milestone payment of USD 250 million. Alexion, AstraZeneca Rare Disease is looking forward to welcoming talent from Amolyt Pharma.

Global Pharma | 14/03/2024 | By Manvi |  523

Poseida Therapeutics Receives FDA Orphan Drug Designation for P-BCMA-ALLO1 in Multiple Myeloma Treatment

P-BCMA-ALLO1 is a BCMA-targeted allogeneic, T stem cell memory (TSCM)-rich chimeric antigen receptor (CAR)-T therapy candidate, currently being investigated in collaboration with Roche for the treatment of relapsed/refractory multiple myeloma (RRMM).

Global Pharma | 14/03/2024 | By Abha |  634

IATA and Pharma.Aero Collaborate to Enhance Pharmaceutical Handling Excellence

The collaborative effort involved meticulous examination of the CEIV Pharma program, engaging certified entities, pharmaceutical manufacturers, and professionals within the air logistics sector.

Global Pharma | 14/03/2024 | By Abha |  730

Silicon Valley Innovations Appoints Thomas M. Krummel to its Board of Directors

Krummel recently received the 2023 Jacobson Innovation Award from the American College of Surgeons, the highest honor nationwide in Surgery, for his pioneering 'life-saving advances in newborn life support' and a 40 year career as an innovator in Surgery.

Global Pharma | 13/03/2024 | By Manvi |  506